Literature DB >> 14508801

Spontaneous rupture of the spleen in AL amyloidosis.

B Oran1, D G Wright, D C Seldin, D McAneny, M Skinner, V Sanchorawala.   

Abstract

The frequency of splenic involvement in AL amyloidosis is not precisely known. However, splenomegaly has been reported in 4-13% of patients. We report four cases of spontaneous splenic rupture in patients with AL amyloidosis. Splenic rupture was the initial manifestation of the disease in one of these patients. The other three experienced splenic rupture during or after high-dose intravenous melphalan with autologous peripheral blood stem cell transplantation (HDM/SCT): one during stem cell mobilization with G-CSF prior to HDM/SCT and two after hematopoietic recovery following treatment. Two of the four patients had Factor X deficiency, the most common coagulation abnormality associated with AL amyloidosis. All four patients underwent splenectomy without significant postoperative complications. Splenic rupture in AL amyloidosis as a complication of aggressive treatment with HDM/SCT has not been reported previously. Copyright 2003 Wiley-Liss Inc.

Entities:  

Mesh:

Year:  2003        PMID: 14508801     DOI: 10.1002/ajh.10389

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  10 in total

1.  Role of high-dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis.

Authors:  Vaishali Sanchorawala
Journal:  Am J Blood Res       Date:  2012-01-01

2.  [Rupture of the spleen. Clinicopathological correlations and diagnostic procedures].

Authors:  A Tzankov; H Adams; W Sterlacci
Journal:  Pathologe       Date:  2008-03       Impact factor: 1.011

3.  Large B-cell lymphoma presenting as acute abdominal pain and spontaneous splenic rupture; a case report and review of relevant literature.

Authors:  Saptarshi Biswas; Judith Keddington; James McClanathan
Journal:  World J Emerg Surg       Date:  2006-11-28       Impact factor: 5.469

Review 4.  Splenic rupture following lenograstim in post-autologous stem cell transplantation treated with emergency open splenectomy: a case report and literature review.

Authors:  Uros Markovic; Cristina Colarossi; Antonio Iuppa; Paola Scire; Ausilia Gorgone; Federica Galbo; Gabriella Amato; Gaetano Moschetti
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573

5.  Current treatment in cardiac amyloidosis.

Authors:  Ivana Kholová; Josef Kautzner
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-12

6.  Effectiveness and Safety of Pegfilgrastim in BEP Treatment for Patients with Germ Cell Tumor.

Authors:  Hiroaki Iwamoto; Kouji Izumi; Ariunbold Natsagdorj; Tomoyuki Makino; Takahiro Nohara; Kazuyoshi Shigehara; Yoshifumi Kadono; Atsushi Mizokami
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

Review 7.  Amyloidosis.

Authors:  Raymond L Comenzo
Journal:  Curr Treat Options Oncol       Date:  2006-05

8.  Spontaneous bilateral kidney rupture during autologous stem cell transplantation in a patient affected by amyloidosis.

Authors:  Michele Ferrannini; Gisella Vischini; Gottardo De Angelis; Konstantinos Giannakakis; William Arcese
Journal:  NDT Plus       Date:  2010-10-05

9.  Atraumatic Splenic Rupture Due to Ectopic Extramedullary Hematopoiesis after Autologous Stem Cell Transplantation in a Patient with AL Amyloidosis.

Authors:  Shuku Sato; Yotaro Tamai; Satomi Okada; Emiko Kannbe; Kotaro Takeda; Eri Tanaka
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

Review 10.  613 cases of splenic rupture without risk factors or previously diagnosed disease: a systematic review.

Authors:  F Kris Aubrey-Bassler; Nicholas Sowers
Journal:  BMC Emerg Med       Date:  2012-08-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.